Systematic Financial Management LP increased its stake in shares of Aceto Corp. (NASDAQ:ACET) by 5.5% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 82,065 shares of the company’s stock after buying an additional 4,295 shares during the period. Systematic Financial Management LP owned about 0.28% of Aceto Corp. worth $1,796,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. Prudential Financial Inc. boosted its position in shares of Aceto Corp. by 2.8% in the first quarter. Prudential Financial Inc. now owns 70,671 shares of the company’s stock valued at $1,665,000 after buying an additional 1,900 shares in the last quarter. Glenmede Trust Co. NA boosted its position in shares of Aceto Corp. by 53.2% in the second quarter. Glenmede Trust Co. NA now owns 102,443 shares of the company’s stock valued at $2,242,000 after buying an additional 35,578 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Aceto Corp. by 57.2% in the first quarter. Goldman Sachs Group Inc. now owns 47,926 shares of the company’s stock valued at $1,129,000 after buying an additional 17,441 shares in the last quarter. Alambic Investment Management L.P. boosted its position in shares of Aceto Corp. by 241.2% in the second quarter. Alambic Investment Management L.P. now owns 53,511 shares of the company’s stock valued at $1,171,000 after buying an additional 37,826 shares in the last quarter. Finally, TIAA CREF Investment Management LLC boosted its position in shares of Aceto Corp. by 10.8% in the first quarter. TIAA CREF Investment Management LLC now owns 132,047 shares of the company’s stock valued at $3,111,000 after buying an additional 12,886 shares in the last quarter. 86.85% of the stock is owned by hedge funds and other institutional investors.

Aceto Corp. (NASDAQ:ACET) traded up 1.17% during trading on Thursday, hitting $19.47. The stock had a trading volume of 52,759 shares. Aceto Corp. has a 52 week low of $18.25 and a 52 week high of $32.20. The stock has a market capitalization of $577.25 million, a P/E ratio of 16.50 and a beta of 1.36. The company has a 50-day moving average of $22.00 and a 200-day moving average of $22.65.

Aceto Corp. (NASDAQ:ACET) last announced its quarterly earnings data on Thursday, August 25th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.39 by $0.04. Aceto Corp. had a net margin of 6.22% and a return on equity of 15.39%. The firm had revenue of $135.40 million for the quarter, compared to the consensus estimate of $146.71 million. During the same period last year, the company posted $0.40 earnings per share. Aceto Corp.’s revenue for the quarter was down 7.6% on a year-over-year basis. On average, equities analysts expect that Aceto Corp. will post $1.53 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were issued a dividend of $0.065 per share. This represents a $0.26 annualized dividend and a yield of 1.35%. This is a positive change from Aceto Corp.’s previous quarterly dividend of $0.06. The ex-dividend date of this dividend was Wednesday, September 7th. Aceto Corp.’s dividend payout ratio is 22.03%.

A number of equities analysts have recently commented on the company. Craig Hallum reissued a “buy” rating on shares of Aceto Corp. in a report on Monday, August 29th. Zacks Investment Research cut Aceto Corp. from a “hold” rating to a “sell” rating in a report on Monday, July 4th.

In other news, CFO Douglas A. Roth sold 6,770 shares of the firm’s stock in a transaction on Wednesday, July 6th. The stock was sold at an average price of $22.72, for a total value of $153,814.40. Following the completion of the transaction, the chief financial officer now directly owns 58,783 shares of the company’s stock, valued at $1,335,549.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Salvatore J. Sr Guccione, Sr. sold 10,945 shares of the firm’s stock in a transaction on Wednesday, July 6th. The stock was sold at an average price of $23.25, for a total value of $254,471.25. Following the completion of the transaction, the chief executive officer now directly owns 144,042 shares of the company’s stock, valued at $3,348,976.50. The disclosure for this sale can be found here. Company insiders own 3.70% of the company’s stock.

Aceto Corp. Company Profile

Aceto Corporation (Aceto) is engaged in marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products.

5 Day Chart for NASDAQ:ACET

Want to see what other hedge funds are holding ACET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aceto Corp. (NASDAQ:ACET).

Receive News & Ratings for Aceto Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aceto Corp. and related companies with MarketBeat.com's FREE daily email newsletter.